A thiazole derivative of artemisinin moderately reduces toxoplasma gondii cyst burden in infected mice

Journal of Parasitology

Volumn 100, Issue 4, 2014, Pages 516-521

  Schultz, Tracey L ^a   Hencken, Christopher P ^a   Woodard, Lauren E ^a   Posner, Gary H ^a   Yolken, Robert H ^a   Jones Brando, Lorraine ^a   Carruthers, Vern B ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTEMETHER; ARTEMISININ; ATOVAQUONE; CPH 4136; LEW 327; UNCLASSIFIED DRUG;

CYST; DISEASE TREATMENT; ORGANIC COMPOUND; PARASITOLOGY; PROTOZOAN; PUBLIC HEALTH; RODENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CYST; CONTROLLED STUDY; DRUG EFFICACY; DRUG STABILITY; FEMALE; IN VITRO STUDY; INFECTION; LIVER MICROSOME; MOUSE; NONHUMAN; TOXOPLASMA GONDII; TOXOPLASMOSIS;

ANIMALS; ANTIPROTOZOAL AGENTS; ARTEMISININS; BRAIN; CHRONIC DISEASE; DRUG STABILITY; FEMALE; MICE; MICE, INBRED CBA; THIAZOLES; TOXOPLASMA; TOXOPLASMOSIS, ANIMAL;

EID: 84907351386     PISSN: 00223395     EISSN: 19372345     Source Type: Journal    
DOI: 10.1645/13-451.1     Document Type: Article

References (20)

1. Araujo, F. G., P. Prokocimer, T. Lin, AND J. S. Remington. 1992. Activity of clarithromycin alone or in combination with other drugs for treatment of murine toxoplasmosis. Antimicrobial Agents and Chemotherapy 36: 2454-2457
2. Brun-PASCAUD, M., F. Chau, F. Derouin, AND P. M. Girard. 1996. Lack of activity of artemether for prophylaxis and treatment of toxoplasma gondii and Pneumocystis carinii infections in rat. Parasite 3: 187-189
3. D'angelo, J. G., C. Bordon, G. H. Posner, R. Yolken, AND L. Jones Brando. 2009. Artemisinin derivatives inhibit toxoplasma gondii in vitro at multiple steps in the lytic cycle. Journal of Antimicrobial Chemotherapy 63: 146-150
4. Doggett, J. S., A. Nilsen, I. Forquer, K. W. Wegmann, L. Jonesbrando, R. H. Yolken, C. Bordon, S. A. Charman, K. Katneni, T. Schultz, ET AL. 2012. Endochin-like quinolones are highly efficacious against acute and latent experimental toxoplasmosis. Proceedings of the National Academy of Sciences U.S.A. 109: 15936-15941
5. Dunay, I. R., W. C. Chan, R. K. Haynes, AND L. D. Sibley. 2009. Artemisone and artemiside control acute and reactivated toxoplasmosis in a murine model. Antimicrobial Agents and Chemotherapy 53: 4450-4456
6. Goo, Y. K., M. A. Terkawi, H. Jia, G. O.ABOGE, H. Ooka, B. Nelson, S. Kim, F. Sunaga, K. Namikawa, I. Igarashi, ET AL. 2010. Artesunate, a potential drug for treatment of Babesia infection. Parasitology International 59: 481-486
7. Hencken, C. P., L. Jones-BRANDO, C. Bordon, R. Stohler, B. T. Mott, R. Yolken, G. H. Posner, AND L. E. Woodard. 2010. Thiazole, oxadiazole, and carboxamide derivatives of artemisinin are highly selective and potent inhibitors of toxoplasma gondii. Journal of Medicinal Chemistry 53: 3594-3601
8. Ke, O. Y., E. C. Krug, J. J. Marr, AND R. L. Berens. 1990. Inhibition of growth of toxoplasma gondii by Qinghaosu and derivatives. Antimicrobial Agents and Chemotherapy 34: 1961-1965
9. Keiser, J., L. Rinaldi, V. Veneziano, L. Mezzino, M. Tanner, J. Utzinger, AND G. CRINGOLI. 2008. Efficacy and safety of artemether against a natural Fasciola hepatica infection in sheep. Parasitology Research 103: 517-522
10. Koppe, J. G., D. H. Loewer-SIEGER, AND H. DE ROEVER-BONNET. 1986. Results of 20-year follow-up of congenital toxoplasmosis. Lancet 1: 254-256
11. Lambert, H., N. Hitziger, I. Dellacasa, M. Svensson, AND A. BARRAGAN. 2006. Induction of dendritic cell migration upon toxoplasma gondii infection potentiates parasite dissemination. Cellular Microbiology 8: 1611-1623
12. Mazuz, M. L., R. Haynes, V. Shkap, L. Fish, R. Wollkomirsky, B. Leibovich, T. Molad, I. Savitsky, AND J. Golenser. 2012. Neospora caninum: In vivo and in vitro treatment with artemisone. Veterinary Parasitology 187: 99-104
13. Nagamune, K., W. L. Beatty, AND L. D. Sibley. 2007. Artemisinin induces calcium-dependent protein secretion in the protozoan parasite toxoplasma gondii. Eukaryotic Cell 6: 2147-2156
14. Nagamune, K., S. N. Moreno, AND L. D. Sibley. 2007. Artemisinin-resistant mutants of toxoplasma gondii have altered calcium homeostasis. Antimicrobial Agents and Chemotherapy 51: 3816-3823
15. Pearce, B. D., D. Kruszon-MORAN, AND J. L. Jones. 2012. The relationship between toxoplasma gondii infection and mood disorders in the third national health and nutrition survey. Biological Psychiatry 72: 290-295
16. Posner, G. H., I. H. Paik, W. Chang, K. Borstnik, S. Sinishtaj, A. S. Rosenthal, AND T. SHAPIRO. 2007. Malaria-infected mice are cured by a single dose of novel artemisinin derivatives. Journal of Medicinal Chemistry 50: 2516-2519
17. Sen, R., S. Ganguly, P. Saha, AND M. CHATTERJEE. 2010. Efficacy of artemisinin in experimental visceral leishmaniasis. International Journal of Antimicrobial Agents 36: 43-49
18. Suzuki, Y., K. Joh, M. A. Orellana, F. K. Conley, AND J. S. Remington. 1991. A gene(s) within the H-2D region determines the development of toxoplasmic encephalitis in mice. Immunology 74: 732-739
19. Torrey, E. F., J. J. Bartko, AND R. H. Yolken. 2012. toxoplasma gondii and other risk factors for schizophrenia: An update. Schizophrenia Bulletin 38: 642-647
20. Xiao, S., M. Tanner, E. K. N'goran, J. Utzinger, J. Chollet, R. Bergquist, M. Chen, AND J. ZHENG. 2002. Recent investigations of artemether, a novel agent for the prevention of schistosomiasis japonica, mansoni and haematobia. Acta Tropica 82: 175-181